9 Meters Biopharma, Inc. (NMTRQ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Feb 12, 2026, 9:30 AM EST

9 Meters Biopharma Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Mar '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Cash & Equivalents
6.9412.6546.9937.854.595.73
Cash & Short-Term Investments
6.9412.6546.9937.854.595.73
Cash Growth
-81.37%-73.09%24.15%724.12%-19.83%1511.22%
Prepaid Expenses
1.573.362.9910.560.5
Restricted Cash
0.6817.01----
Other Current Assets
---0.080.080.18
Total Current Assets
9.233.0249.9938.935.226.41
Property, Plant & Equipment
0.110.120.180.230.070.04
Other Long-Term Assets
0.010.010.010.010.010.01
Total Assets
9.3133.1550.1739.165.36.45
Accounts Payable
4.235.052.431.493.893.62
Accrued Expenses
5.764.385.975.294.750.93
Short-Term Debt
5.07--0.013.185.2
Current Portion of Long-Term Debt
-19.62----
Current Portion of Leases
0.060.060.050.050.04-
Other Current Liabilities
0.451.59-0.013.050.37
Total Current Liabilities
15.5830.78.466.8514.9110.11
Long-Term Leases
0.030.050.110.17--
Total Liabilities
15.6130.758.577.0214.9110.11
Common Stock
0000.0200
Additional Paid-In Capital
220.17215.01210.44164.1860.9539.85
Retained Earnings
-226.48-212.61-168.84-132.06-70.56-43.52
Shareholders' Equity
-6.32.441.632.14-9.61-3.66
Total Liabilities & Equity
9.3133.1550.1739.165.36.45
Total Debt
5.1719.730.170.233.235.2
Net Cash (Debt)
1.77-7.0846.8337.621.370.53
Net Cash Growth
-95.23%-24.47%2655.19%156.55%-
Net Cash Per Share
0.13-0.553.857.120.820.43
Filing Date Shares Outstanding
14.4614.3412.9110.82.071.34
Total Common Shares Outstanding
14.3413.0412.9110.231.971.3
Working Capital
-6.382.3241.5332.08-9.69-3.7
Book Value Per Share
-0.440.183.223.14-4.87-2.81
Tangible Book Value
-6.32.441.632.14-9.61-3.66
Tangible Book Value Per Share
-0.440.183.223.14-4.87-2.81
Machinery
-0.060.060.040.050.03
Leasehold Improvements
-0.030.030.030.030.03
Updated May 15, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.